gene_symbol
NTRK3
hgnc_id
HGNC:8033
binding_type
other
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Entrectinib directly inhibits TRKC (NTRK3) kinase activity by binding the ATP site, blocking MAPK and PI3K/AKT signaling in TRKC-driven tumor cells, leading to growth arrest and apoptosis.
enzyme_product
On
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
ATP-competitive kinase domain inhibitor
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05834348
disease_id_num_tar_ref
3350
drug_id_num_tar_ref
9048